Work

Effectiveness of Baricitinib in the Basic Therapy of Active Rheumatoid Arthritis

Year: 2025

Type: article

Abstract: The purpose of our study was to evaluate the efficacy and safety of baricitinib (BARI) in patients with rheumatoid arthritis (RA) who have not achieved low activity or remission according to EULAR criteria under the influence of synthetic disease-modifying drugs or biological agents.

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.14964694

Authors: Muhammadieva, S.M., Abdusolieva, Z.T., Nabidzhonova, D.D.

Language: English

Topic: Rheumatoid Arthritis Research and Therapies

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W6893112102

FWCI:

Cites:

Cited by:

Related to: